(BFM Stock Exchange) – Based on a graphic argument, BFM Stock Exchange analysts have selected Equasens (ex -Halermagest) for active investors.
Key graphics elements
In suffering since the reversal in M (double summit) in October, the title of the specialist in software packages for pharmacies nevertheless offers, punctually, attractive entry points for the most active investors. While the relative force indicator comes out of its occurrence zone, a purely technical protest reaction is the privileged short term scenario.
FORECAST
In view of the key graphic factors that we have mentioned, our opinion is bullish on the Equasens action (ex-pharmagest) in the short term.
Active investors will take a position on the purchase on the Equasens title (ex-Harmagest) during € 37.25 with a target at € 44,900 in sight. They will protect their capital by placing a stop at € 34,890.
The News Bulletin 247 Council
Daily data graphics
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
